Benjamin P. Linas, MD

Associate Professor, Epidemiology

Benjamin Linas
617.414.5238

Biography

Dr. Linas is a national leader in hepatitis-C virus (HCV) infection and HCV/HIV co-infection comparative- and cost-effectiveness research using computational biology, clinical epidemiology and clinical economics methods. Dr. Linas has an excellent track record of productivity, ample funding from the NIH and CDC, and a growing core of successful trainees. Dr. Linas directs the HIV/HCV core of the Center for Health Economics of Treatment Interventions for Substance Use Disorders, HCV, and HIV, funded by the National Institute on Drug Abuse (NIDA) in collaboration with Cornell, U Penn and Miami.

Other Positions

  • Associate Professor, Infectious Diseases, Medicine, Boston University School of Medicine

Education

  • New York University School of Medicine, MD
  • Harvard School of Public Health, MPH
  • Yale University, BA

Publications

  • Published on 3/17/2020

    Assoumou SA, Tasillo A, Vellozzi C, Eftekhari Yazdi G, Wang J, Nolen S, Hagan L, Thompson W, Randall LM, Strick L, Salomon JA, Linas BP. Cost-effectiveness and Budgetary Impact of Hepatitis C Virus Testing, Treatment, and Linkage to Care in US Prisons. Clin Infect Dis. 2020 Mar 17; 70(7):1388-1396. PMID: 31095676.

    Read at: PubMed
  • Published on 3/17/2020

    Gutkind S, Schackman BR, Morgan JR, Leff JA, Agyemang L, Murphy SM, Akiyama MJ, Norton BL, Litwin AH, Linas BP. Cost-effectiveness of Hepatitis C Virus Treatment Models for People Who Inject Drugs in Opioid Agonist Treatment Programs. Clin Infect Dis. 2020 Mar 17; 70(7):1397-1405. PMID: 31095683.

    Read at: PubMed
  • Published on 3/4/2020

    Assoumou SA, Wang J, Nolen S, Eftekhari Yazdi G, Mayer KH, Puro J, Salomon JA, Linas BP. HCV Testing and Treatment in a National Sample of US Federally Qualified Health Centers during the Opioid Epidemic. J Gen Intern Med. 2020 Mar 04. PMID: 32133577.

    Read at: PubMed
  • Published on 2/1/2020

    Ghany MG, Morgan TR. Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. Hepatology. 2020 Feb; 71(2):686-721. PMID: 31816111.

    Read at: PubMed
  • Published on 1/30/2020

    Linas BP. Time for a New Approach to Guidance for HIV and HCV Testing Among Persons Who Inject Drugs. J Infect Dis. 2020 Jan 30. PMID: 32002538.

    Read at: PubMed
  • Published on 1/20/2020

    Moloney PB, Hutchinson S, Heskin J, Mulcahy F, Langan Y, Conlon NP, Linas BP, Takahashi C, Cervantes-Arslanian AM. Possible N-methyl-D-aspartate receptor antibody-mediated encephalitis in the setting of HIV cerebrospinal fluid escape. J Neurol. 2020 Jan 20. PMID: 31960135.

    Read at: PubMed
  • Published on 12/10/2019

    Epstein RL, Wang J, Hagan L, Mayer KH, Puro J, Linas BP, Assoumou SA. Hepatitis C Virus Antibody Testing Among 13- to 21-Year-Olds in a Large Sample of US Federally Qualified Health Centers. JAMA. 2019 12 10; 322(22):2245-2248. PMID: 31821424.

    Read at: PubMed
  • Published on 11/15/2019

    Bellerose M, Zhu L, Hagan LM, Thompson WW, Randall LM, Malyuta Y, Salomon JA, Linas BP. A review of network simulation models of hepatitis C virus and HIV among people who inject drugs. Int J Drug Policy. 2019 Nov 15; 102580. PMID: 31740175.

    Read at: PubMed
  • Published on 10/10/2019

    Kimmel SD, Walley AY, Linas BP, Kalesan B, Awtry E, Dobrilovic N, White L, LaRochelle M. Effect of Publicly Reported Aortic Valve Surgery Outcomes on Valve Surgery in Injection Drug- and Non-Injection Drug-Associated Endocarditis. Clin Infect Dis. 2019 Oct 10. PMID: 31598642.

    Read at: PubMed
  • Published on 7/3/2019

    Linas BP. The 340B System-A Paradox Revealed. JAMA Netw Open. 2019 Jul 03; 2(7):e196537. PMID: 31276173.

    Read at: PubMed

View 81 more publications: View full profile at BUMC

View all profiles